Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB-RWLC vs CENOBAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB-RWLC vs CENOBAMATE: Safety Overview

Metric CEMIPLIMAB-RWLC CENOBAMATE
Total FAERS Reports 1,554 5,643
Deaths Reported 323 125
Death Rate 20.8% 2.2%
Hospitalizations 441 1,012
Average Patient Age 70.2 yrs 38.2 yrs
% Female Patients 40.6% 56.4%
FDA Approval Date N/A Mar 10, 2020
Manufacturer N/A SK Life Science, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription